Updated Jul 16, 2026
Otero Jose Manuel has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $79K.
Jose Manuel Otero is the Chief Technical Officer at Lexeo Therapeutics, Inc., a clinical-stage genetic medicines company. He has been involved in the company's efforts to develop innovative gene therapies for hereditary and acquired diseases.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | LXEO | Lexeo Therapeutics, Inc. | S — Open-market sale | 4.7K | $4.48 | $21K |
| 2026-07-01 | LXEO | Lexeo Therapeutics, Inc. | A — Grant or award | 12.1K | $0.00 | |
| 2026-05-20 | LXEO | Lexeo Therapeutics, Inc. | S — Open-market sale | 1.3K | $5.07 | $7K |
| 2026-03-18 | LXEO | Lexeo Therapeutics, Inc. | A — Grant or award | 5.9K | $2.64 | $16K |
| 2026-02-20 | LXEO | Lexeo Therapeutics, Inc. | S — Open-market sale | 3.0K | $6.40 | $19K |
| 2026-02-06 | LXEO | Lexeo Therapeutics, Inc. | A — Grant or award | 65.0K | $0.00 | |
| 2025-10-15 | LXEO | Lexeo Therapeutics, Inc. | S — Open-market sale | 24 | $9.56 | $229 |
| 2025-10-15 | LXEO | Lexeo Therapeutics, Inc. | S — Open-market sale | 2.1K | $8.94 | $19K |
| 2025-10-15 | LXEO | Lexeo Therapeutics, Inc. | A — Grant or award | 5.9K | $0.00 | |
| 2025-08-18 | LXEO | Lexeo Therapeutics, Inc. | S — Open-market sale | 2.8K | $4.67 | $13K |
Jose Manuel Otero is the Chief Technical Officer at Lexeo Therapeutics, Inc., a clinical-stage genetic medicines company. He has been involved in the company's efforts to develop innovative gene therapies for hereditary and acquired diseases.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($79K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Otero Jose Manuel profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.